GlassScriptPhysician profile
Faraz Khan Luni
NPI 1891070942
$17,141.29
in general payments reported to CMS, 2019-2025
33 companies · $3,566 in 2025
The $3,566 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,021 · 2020: $1,995 · 2021: $1,057 · 2022: $1,050 · 2023: $1,896 · 2024: $4,556 · 2025: $3,566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,055 · Travel and Lodging: $2,963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,054.60 |
| Travel and Lodging | $2,962.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,175.77 | 2019-2025 | Aveir, Ensite, Accent |
| Medtronic, INC. | $3,746.63 | 2022-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Adapta |
| Boston Scientific Corporation | $2,269.86 | 2020-2025 | Farapulse, General - Ep, Watchman Access System |
| Medtronic Vascular, INC. | $1,656.39 | 2019 | |
| Biotronik INC. | $986.85 | 2019-2022 | |
| Biosense Webster, INC. | $547.67 | 2020-2025 | Carto 3 |
| Pfizer INC. | $493.21 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $411.74 | 2020-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $228.15 | 2023-2025 | Verquvo, Winrevair |
| E.R. Squibb & Sons, L.L.C. | $213.84 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.36 | 2022-2025 | Jardiance |
| Amgen INC. | $177.46 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $158.92 | 2021-2025 | |
| Actelion Pharmaceuticals US, INC. | $142.20 | 2021-2025 | Uptravi, Opsumit |
| Zoll Respicardia, INC. | $131.59 | 2024 | Remede System |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altathera Pharmaceuticals LLC | $89.47 | 2021-2023 | Sotalol Hydrochloride |
| Baxter Healthcare | $71.65 | 2023-2024 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $60.18 | 2022-2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $50.40 | 2024 | Optimizer |
| Alnylam Pharmaceuticals INC. | $45.82 | 2024-2025 | Amvuttra |
| Lexicon Pharmaceuticals, INC. | $44.76 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $37.95 | 2021-2023 | Farxiga |
| Amarin Pharma, INC. | $29.14 | 2021-2022 | |
| Bridgebio Pharma, INC. | $28.09 | 2025 | Attruby |
| Philips North America LLC | $24.37 | 2025 | Mcot |
| Vifor Pharma, INC. | $22.13 | 2021 | |
| Edwards Lifesciences Corporation | $20.06 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $19.01 | 2023 | Ozempic |
| Genzyme Corporation | $16.12 | 2021 | |
| Esperion Therapeutics, INC. | $14.30 | 2021 | |
| Arbor Pharmaceuticals, INC. | $14.08 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $13.94 | 2024 | Arcalyst |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faraz Luni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.